Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.94
+0.22 (1.40%)
Nov 10, 2026, 4:08 PM HKT

HKG:1877 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,4912,6152,5023,7885,9973,507
Short-Term Investments
----17.93-
Trading Asset Securities
878.85600.78430.51---
Cash & Short-Term Investments
4,3703,2162,9333,7886,0153,507
Cash Growth
33.62%9.65%-22.58%-37.02%71.53%3.59%
Accounts Receivable
530.01506.75509.82483.23232.731,301
Other Receivables
105.25-36.44374.0178.8128.05
Receivables
635.26506.75546.26857.23314.251,329
Inventory
519.65573.11584.47538.05599.02484.6
Prepaid Expenses
----239.82-
Other Current Assets
156.45162.01220.38387.5936.94524.79
Total Current Assets
5,6814,4584,2845,5717,2055,845
Property, Plant & Equipment
5,1984,8724,1953,8093,2782,801
Long-Term Investments
2,7681,9141,2261,1331,2921,485
Other Intangible Assets
533.35559.77521.41546.9698.91264.98
Long-Term Deferred Tax Assets
124.0488.3187.05103.4228.4388.55
Long-Term Deferred Charges
8.949.766.1212.6-27.79
Other Long-Term Assets
609.91480.35461.94167.14473.39522.34
Total Assets
14,92312,38210,78211,34312,57611,035

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,06173.99115.9125.19370.2363.17
Accrued Expenses
219.49804.98901.441,046917.211,603
Short-Term Debt
617.68603.2678.11452.44391.75-
Current Portion of Long-Term Debt
767.45659.39216.586.96-10.6
Current Portion of Leases
-32.0130.2935.9343.6634.47
Current Income Taxes Payable
32.494.7612.4117.98-63.08
Current Unearned Revenue
36.8422.188.17146.30.4445.8
Other Current Liabilities
32.33577.77531.11527.9250.96181.59
Total Current Liabilities
2,7682,7782,4942,4381,7742,001
Long-Term Debt
5,3732,7941,9801,196839.58490
Long-Term Leases
64.2756.6226.3117.4546.5993.13
Long-Term Unearned Revenue
160.66167.17181.91183.46121.62122.46
Other Long-Term Liabilities
525.59530.06168187.15-11.5
Total Liabilities
8,8916,3264,8504,0222,7822,719

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,0271,027985.69985.69982.87910.76
Additional Paid-In Capital
16,36716,41715,40715,395-11,423
Retained Earnings
-11,365-11,216-10,341-9,060--4,389
Treasury Stock
-30.89-30.89-30.89-26.89--
Comprehensive Income & Other
-166.85-166.69-159.94-142.078,5190.21
Total Common Equity
5,8316,0305,8607,1519,5017,945
Minority Interest
201.3826.1671.71169.39292.83371.28
Shareholders' Equity
6,0326,0575,9327,3219,7948,316
Total Liabilities & Equity
14,92312,38210,78211,34312,57611,035

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
6,8234,1452,9311,7891,322628.19
Net Cash (Debt)
-2,453-928.981.822,0004,6932,878
Net Cash Growth
---99.91%-57.39%63.05%13.58%
Net Cash Per Share
-2.43-0.920.002.035.123.23
Filing Date Shares Outstanding
1,0261,026984.87985.01982.87910.76
Total Common Shares Outstanding
1,0261,026984.87985.01982.87910.76
Working Capital
2,9141,6791,7903,1335,4313,843
Book Value Per Share
5.685.885.957.269.678.72
Tangible Book Value
5,2975,4715,3396,6049,4037,680
Tangible Book Value Per Share
5.165.335.426.709.578.43
Buildings
-1,4251,3791,419-891.83
Machinery
-2,1612,0221,9211,5221,419
Construction In Progress
-2,5721,8591,3251,048801.93
Leasehold Improvements
----65.57-